Professor Stefano Aliberti, MD

Professor Stefano Aliberti, MD


Professor in Respiratory Medicine
Humanitas University
Chief, Pulmonary Department
IRCCS Humanitas Research Hospital
Milan, Italy

Related Videos

The Critical Role of Longitudinal Microbiologic Monitoring in MAC Lung Disease<br><sub>The Potential Pitfalls of a “Watch and Wait” Approach in High-Risk Patients</sub> Video

The Critical Role of Longitudinal Microbiologic Monitoring in MAC Lung Disease
The Potential Pitfalls of a “Watch and Wait” Approach in High-Risk Patients

Optimizing Management of MAC Lung Disease with Guideline-Based Therapy<br><sub>Current, Evidence- and Trial-Based Recommendations for Applying ATS/IDSA/ERS/ESCMID Treatment Plans for NTM-PD</sub> Video

Optimizing Management of MAC Lung Disease with Guideline-Based Therapy
Current, Evidence- and Trial-Based Recommendations for Applying ATS/IDSA/ERS/ESCMID Treatment Plans for NTM-PD

From Clinical Suspicion and Co-Morbid Risk Factors to Diagnostic Confirmation of MAC Lung Disease Video

From Clinical Suspicion and Co-Morbid Risk Factors to Diagnostic Confirmation of MAC Lung Disease

The Critical Role of Bronchiectasis, COPD, and TB as Risk Factors for MAC Lung Disease and Implications for Treatment.

From Clinical Suspicion and Co-Morbid Risk Factors to Diagnostic Confirmation of MAC Lung Disease Video

From Clinical Suspicion and Co-Morbid Risk Factors to Diagnostic Confirmation of MAC Lung Disease

The Critical Role of Bronchiectasis, COPD, and TB as Risk Factors for MAC Lung Disease and Implications for Treatment.

Antimicrobial Decision-Making in MAC Lung Disease<br><sub>When Prompt Therapy is Preferred Over a “Watch and Wait” Approach in NTM Pulmonary Disease with Limited Options</sub> Video

Antimicrobial Decision-Making in MAC Lung Disease
When Prompt Therapy is Preferred Over a “Watch and Wait” Approach in NTM Pulmonary Disease with Limited Options